Clinical Pharmacology of Antiepileptic Drug Use: “Clinical Pearls about the Perils of Patty”

The Journal of Clinical Pharmacology

Volumn 35, Issue 12, 1995, Pages 1120-1135

  Schraeder, Paul L ^a   Lathers, Claire M ^b,c,d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NASA HEADQUARTERS   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; GENERIC DRUG; ISONIAZID; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

BEHAVIOR DISORDER; CLINICAL EDUCATION; CLINICAL PHARMACOLOGY; COMPLEX PARTIAL SEIZURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; EPILEPSY; FEBRILE CONVULSION; GINGIVA HYPERPLASIA; HUMAN; LEARNING DISORDER; NEURAL TUBE DEFECT; PREGNANCY; PROBLEM SOLVING; REVIEW; SELF EVALUATION; SPINA BIFIDA; TERATOGENICITY;

EID: 0029563456     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1995.tb04037.x     Document Type: Article

References (9)

1. Mechanisms of teratogenesis: folic acid and antiepileptic therapy
2. Clinical and experimental studies linking oxidative metabolism to phenytoin‐induced teratogenesis
3. Drugs effective in the therapy of the epilepsies
4. Pharmacogenetics and drug interactions: role in antiepileptic‐drug‐induced teratogenesis
5. Double‐blind randomized study comparing brand‐name and generic phenytoin monotherapy
6. Rational use of antiepileptic drug levels
7. Antiepileptic drug disposition during pregnancy